Jubilant Life raises Rs 100 crore by issue of commercial papers
Tuesday, April 18, 2017, 2:53 PM
Drug firm Jubilant Life Sciences today said it has raised Rs 100 crore through issuing commercial papers. The company has issued commercial papers of Rs 100 crore on April 18, 2017. The tenure of an instrument is 63 days, Jubilant Life Sciences said in a BSE filing. The company, however, did not specify what it planned to do with the money raised.